GIPALANINThe Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

This study aims to explore how two substances, glucose-dependent insulinotropic polypeptide (GIP) and alanine, influence hormone levels in healthy men. Researchers want to see if these substances, given separately or together, can increase the levels of glucagon, a hormone that raises blood sugar levels, under normal blood sugar conditions. Understanding these effects can help advance knowledge about how gut hormones and amino acids interact, which could potentially lead to better treatments for managing blood sugar levels. Participants in this study receive an intravenous infusion of either a placebo, GIP, alanine, or a combination of GIP and alanine on four different days. Each session lasts 90 minutes, and the order in which they receive these treatments is randomized. The study evaluates how these treatments affect glucagon levels, insulin secretion, and the concentration of various amino acids in the blood. Since the study is double-blinded, neither the participants nor the researchers know which treatment is being administered on a given day, reducing bias and ensuring more reliable results.